Daily Tadalafil in Diabetic ED Patients
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexMale
Age30-60
SponsorSouth Valley University
About this trial
This study evaluates the effect of 5 mg daily tadalafil therapy on serum levels of Endothelin-1 and E-selectin in diabetic male patients with erectile dysfunction. Outcomes will be compared pre- and post-treatment versus healthy controls.
Eligibility criteria
Qualifiers
None
Disqualifiers
None
Trial design
Treatments tested in this trial
- Methyl Cellulose Placebo
Treatment groups
60 Participants
are divided into 2 treatment groupsLocations
This trial has no locations
Sponsors and collaborators
South Valley University
Lead sponsor
Source ClinicalTrials.gov